Sign inJoin waitlistJoin the waitlist

Christine Higham

Program Director · University of California (San Francisco) School of Medicine

Credentials: · · · · · ·

History

Pediatric Hematology Oncology
Children's National Hospital
2013–2016
Pediatrics
McGaw Medical Center of Northwestern University
2010–2013
Boston University School of Medicine
2006–2010

Research

Inhibition of B Cell Receptor Signaling by Ibrutinib in Primary CNS Lymphoma
Cancer Cell · 2017 · 425 citations
Low mutation burden and frequent loss of CDKN2A/B and SMARCA2, but not PRC2, define premalignant neurofibromatosis type 1-associated atypical neurofibromas
Systematic review or meta-analysis · Neuro-Oncology · 2019 · 97 citations
Transplant-Associated Thrombotic Microangiopathy in Pediatric Hematopoietic Cell Transplant Recipients: A Practical Approach to Diagnosis and Management
Review · Frontiers in Pediatrics · 2019 · 92 citations

Christopher Dvorak
22 papers
Kristin Shimano
12 papers
Sandhya Kharbanda
12 papers
James Huang
10 papers
Lena Winestone
10 papers
Julia Chu
8 papers
AM
Alexis Melton
6 papers
Matt Zinter
6 papers
Michelle Schoettler
6 papers
GC
Geoffrey Cheng
5 papers
JD
Jasmeen Dara
5 papers
Nahal Lalefar
5 papers

Clinical trials

Defibrotide Prophylaxis of Transplant Associated-Thrombotic Microangiopathy for Neuroblastoma
Principal investigator · Withdrawn · Phase 2
University of California, San Francisco
2024–2027
Defibrotide TMA Prophylaxis Pilot Trial
Principal investigator · Completed · Phase 2
University of California, San Francisco
2018–2020
The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALL
Site PI · Recruiting · Phase 2
Pediatric Transplantation & Cellular Therapy Consortium
2018–2026